Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction

被引:36
作者
Setoguchi, Masahiko [1 ,2 ]
Hashimoto, Yuji [1 ]
Sasaoka, Taro [2 ]
Ashikaga, Takashi [2 ]
Isobe, Mitsuaki [2 ]
机构
[1] Kameda Gen Hosp, Dept Cardiol, Kamogawa, Japan
[2] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138519, Japan
关键词
Inferior vena cava; Depression; Heart failure with preserved ejection fraction; Readmission; INITIATE LIFESAVING TREATMENT; HOSPITALIZED-PATIENTS; NATRIURETIC PEPTIDE; CLINICAL-OUTCOMES; ORGANIZED PROGRAM; BETA-BLOCKER; OPTIMIZE-HF; PREVALENCE; MORTALITY; DISCHARGE;
D O I
10.1007/s00380-014-0532-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although there have been several studies regarding heart failure with preserved ejection fraction (HFpEF), investigations of the risk factors for readmission of Japanese patients with HFpEF remain scarce. Therefore, our goal was to identify the risk factors for readmission of Japanese patients with heart failure (HF), particularly those with HFpEF. We analyzed 310 patients who were hospitalized for the first time with HF. Preserved EF was defined EF a parts per thousand yen50 %, and reduced EF (rEF) was EF < 50 %. The study endpoint was readmission for HF after discharge. Medical history, vital signs, electrocardiograms, chest radiographs, blood tests and echocardiograms were compared between patients with HFpEF and with HFrEF. Among the 142 patients who had HFpEF, 43 reached the endpoint within 1 year. Multivariate analysis revealed depression (HR: 7.185), high brain natriuretic peptide (BNP) levels at discharge (HR: 1.003), and dilated inferior vena cava (HR: 1.100) as independent risk factors for readmission. In contrast, 39 of the 168 patients with HFrEF reached the endpoint. Risk factors for readmission of HFrEF patients were low sodium (HR: 0.856), high blood urea nitrogen (HR: 1.045), high BNP levels at discharge (HR: 1.003) and absence of beta-blocker prescription (HR: 0.395). In conclusion, our study suggests that the predictors of HF readmission differ between HFpEF and HFrEF patients.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 50 条
[21]   Heart Failure with Preserved Ejection Fraction [J].
Franssen, C. ;
Paulus, W. J. .
NETHERLANDS JOURNAL OF CRITICAL CARE, 2012, 16 (04) :125-132
[22]   Heart failure with a preserved ejection fraction [J].
Warriner, D. R. ;
Morris, P. D. ;
Saraf, K. ;
Al-Mohammad, A. .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (02) :C26-C30
[23]   Heart failure with preserved ejection fraction [J].
Harper, Andrew R. ;
Patel, Hitesh C. ;
Lyon, Alexander R. .
CLINICAL MEDICINE, 2018, 18 (02) :S24-S29
[24]   Heart failure with preserved ejection fraction [J].
Donal, E. .
REVUE DE MEDECINE INTERNE, 2008, 29 :S6-S7
[25]   Pharmacologic Management of Heart Failure with Preserved Ejection Fraction [J].
Huang, Dana ;
Cheng, Judy W. M. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (12) :1933-1945
[26]   Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction [J].
Yamamoto, Kazuhiro .
YONAGO ACTA MEDICA, 2017, 60 (02) :71-76
[27]   Heart Failure With Preserved Ejection Fraction [J].
Borlaug, Barry A. ;
Sharma, Kavita ;
Shah, Sanjiv J. ;
Ho, Jennifer E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (18) :1810-1834
[28]   Heart Failure with Preserved Ejection Fraction [J].
Redfield, Margaret M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1868-1877
[29]   Heart failure with preserved ejection fraction [J].
Rigolli, Marzia ;
Whalley, Gillian A. .
JOURNAL OF GERIATRIC CARDIOLOGY, 2013, 10 (04) :369-376
[30]   Treatment of Heart Failure with Preserved Ejection Fraction [J].
Barnes, Megan M. ;
Dorsch, Michael P. ;
Hummel, Scott L. ;
Koelling, Todd M. ;
Bleske, Barry E. .
PHARMACOTHERAPY, 2011, 31 (03) :312-331